Fenwal, Inc., a Fresenius Kabi Company

Fenwal, Inc., a Fresenius Kabi Company

Fenwal, Inc., a Fresenius Kabi company, is a global blood technology company founded in 1949 and headquartered in the United States. It is dedicated to supporting transfusion medicine and cell therapies. The company is a subsidiary of leading global healthcare company, Fresenius Kabi, which focuses on medicines and medical devices for critically and chronically ill patients.

Fresenius Kabi, with its roots dating back more than a century, offers a broad portfolio of specialty and generic pharmaceuticals in the US under the APP brand. In 2012, Fresenius Kabi expanded its offering by acquiring Fenwal Inc., thus integrating advanced medical technologies for blood separation, collection, filtration, storage, and transfusion into its product range.

Fenwal's products play a crucial role in ensuring the availability, safety, and effectiveness of treatments that depend on blood, making it a vital natural resource for medicine. As a subsidiary of Fresenius Kabi, Fenwal contributes to the parent company's commitment to providing essential medical solutions for critical care.